UroGen Pharma Announces Encouraging Results from a Phase 1 Dose-Escalation Study Evaluating UGN-301 in Non-Muscle Invasive Bladder Cancer

9 hours ago 1
ARTICLE AD BOX
Read Entire Article
  1. Homepage
  2. Finance
  3. UroGen Pharma Announces Encouraging Results from a Phase 1 Dose-Escalation Study Evaluating UGN-301 in Non-Muscle Invasive Bladder Cancer

Related

Russia stocks higher at close of trade; MOEX Russia Index up 2.10%

Russia stocks higher at close of trade; MOEX Russia Index up...

2 hours ago 0
TikTok to enter Japan e-commerce, Nikkei reports

TikTok to enter Japan e-commerce, Nikkei reports

2 hours ago 1
Trump says American ships should be allowed to travel through the Panama and Suez canals for free

Trump says American ships should be allowed to travel throug...

3 hours ago 1
RIGHT SIDEBAR TOP AD

Trending

1. brahim díaz
2. fermín lópez
3. fc barcelona femení
4. katherine legge
5. real madrid femenino
6. kurtis rourke
7. carson bruener
8. marcus bryant nfl draft
9. scotty pippen jr
10. thomas fidone

Popular

What we know about the New York City helicopter crash that killed 6 people

What we know about the New York City helicopter crash that k...

2 weeks ago 77
Paxton's challenge isn't the only one worrying Senate Republicans

Paxton's challenge isn't the only one worrying Senate Republ...

2 weeks ago 77
Rory McIlroy, Bryson DeChambeau surge; Justin Rose holds slim Masters lead at midway point

Rory McIlroy, Bryson DeChambeau surge; Justin Rose holds sli...

2 weeks ago 67
From classifying immigrants as dead to deportation: A guide to actions on Trump immigration policies

From classifying immigrants as dead to deportation: A guide ...

2 weeks ago 66
Biden reemerges on the attack, but doesn’t mention Trump

Biden reemerges on the attack, but doesn’t mention Trump

1 week ago 63
RIGHT SIDEBAR BOTTOM AD
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Powerbits - breaking news today 2025. All rights are reserved